Skip to main content
. 2014 Jul 3;54(12):1407–1420. doi: 10.1002/jcph.352

Figure 2.

Figure 2

(a) Mean (+SD) plasma rivaroxaban concentrations following administration of rivaroxaban 10 mg in subjects with normal renal function and mild or moderate renal impairment. (b) Mean (+SD) plasma rivaroxaban concentrations following administration of rivaroxaban 10 mg with and without concomitant erythromycin 500 mg tid in subjects with normal renal function. (c) Mean (+SD) plasma rivaroxaban concentration following administration of rivaroxaban 10 mg with and without concomitant erythromycin 500 mg tid in subjects with normal renal function and mild or moderate renal impairment. (d) Mean (+SD) plasma rivaroxaban concentration following administration of rivaroxaban 10 mg with and without concomitant erythromycin 500 mg tid in subjects with mild or moderate renal impairment.